Overview
In Policy Context, Italy’s score is well above the average, having the highest alignment of national care guidelines with international guidelines and the existence of a severe asthma registry being undermined by a limited asthma strategy, the lack of severe asthma guidelines, and limited tobacco control policies. Italy scores within the top third of countries in Access and Care Coverage with a higher-than-average score. This is due to an above-average level of access to treatments (including biologics), access to inflammatory phenotyping-based diagnostics, and high levels of access to telemedicine and remote care. Italy ranks highest in terms of Environmental Factors and is among the top scorers in terms of Disease Burden, with positive, though improvable, performance in the estimated societal cost of severe asthma, asthma DALYs, percentage of deaths attributable to asthma and adult obesity rate.
How does Italy perform in each category?
Provides further insights into how Italy scores across each Index category
Italy takeaways
Data from the Severe Asthma Index revealed the following key insights about severe asthma care in Italy
Italy has the best alignment of national care guidelines with international guidelines among the 29 OECD countries included in the Index
Italy has one of the highest levels of access to inflammatory-phenotyping-based diagnostics
Italy has one of the lowest levels of DALYs attributable to asthma
Compare Italy to other countries
Select different countries to see how they scored across each of the 5 categories and overall